Latest news
Stay up to date with STOP2030
Project news
The REALISE clinical begins sample collection and dosing
Our latest clinical trial has started its clinical phase as sample collection and dosing started in Kenya
Meta-analysis shows age-based fixed ivermectin dosing could transform MDA campaigns
Ivermectin, one of the two medicines used in our fixed-dose[...]
With the Site Initiation Visit Complete, Our Team Prepares to Launch the REALISE Study
The Ghana Health Service (GHS) Research and Development Division, along[...]
EMA adopts positive scientific opinion on our ivermectin/albendazole fixed-dose coformulation
The STOP2030 Consortium is pleased to announce that the Committee[...]
STOP2030 team at InCORNTD 2025
Colleagues from the STOP2030 consortium attended last week the[...]
Our FDC of albendazole & ivermectin demonstrates safety and superior efficacy in phase 2-3 trial
Researchers from African, Latin American and European organisations have published[...]
WHO Publishes the First Guidelines for Controlling Strongyloides stercoralis
Controlling Strongyloides stercoralis: WHO's recommendations for addressing it as a[...]
Our latest popPK study supports the dosing strategy of our ivermectin/albendazole FDC
A new paper on the population pharmacokinetics (PK) of our[...]
ESACIPAC (KEMRI) designated as a WHO Collaborating Centre on NTDs
The Eastern and Southern Africa Centre of International Parasite[...]
